A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Clinical trial NCT06822543 · RECRUITING

Trial details

NCT number: NCT06822543
Sponsor: Latin American Cooperative Oncology Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Cancer Brain Metastases

Start date: 2025-09-12
Primary completion: 2028-06-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.